엔지켐생명과학

183490KOSDAQSector: Pharma & Biotech

₩990 0.00%Market cap ₩83.8BAs of Jul 21, 2026 close · updated once daily

Grade B55.3 ptsTop 44% of 2,523 stocks

Financial strength

65.4

Growth momentum

48.6

Price attractiveness

48.6

As of Jul 21, 2026 close · This grade is not a buy/sell recommendation — it is information mechanically scored from public data using a fixed formula.

Financial strength

65.4

How much debt does it carry relative to equity?

Debt-to-equity ratio

7.1%

✓ Above median · Top 7.5% in sector

Sector median 51.5%

Can it cover what's due within a year?

Current ratio

1406.4%

✓ Above median · Top 10.4% in sector

Sector median 191.3%

How much of revenue becomes profit?

Operating margin

-21.2%

✗ Below median · Top 61.1% in sector

Sector median -2.3%

How much did it earn on its own capital?

ROE (return on equity)

-13.2%

✗ Below median · Top 59.6% in sector

Sector median -4.5%

Source filing: annual report (consolidated) — view original ↗

Growth momentum

48.6

How much did revenue grow in a year?

Revenue growth (YoY)

-12.4%

✗ Below median · Top 83.8% in sector

Sector median 6.4%

Has it grown steadily over three years?

Revenue 3-year CAGR

36.5%

✓ Above median · Top 8.5% in sector

Sector median 4.9%

Did core profits grow in a year?

Operating income change (YoY)

-8.7%

✗ Below median · Top 62.7% in sector

Sector median 3.6%

Are core profits higher than three years ago?

Operating income change (3Y)

2.2%

✗ Below median · Top 50.8% in sector

Sector median 3.5%

Source filing: annual report (consolidated) — view original ↗

Price attractiveness

48.6

Is the price expensive relative to earnings?

P/E (price-to-earnings)

Loss-making (P/E not computable)

✗ Below median · Top 83.9% in sector

Sector median P/E of profitable peers 14.4x · 57% loss-making

Is the price expensive relative to book value?

P/B (price-to-book)

0.61x

✓ Above median · Top 18.9% in sector

Sector median 1.39x

Valuation uses the Jul 21, 2026 close and market cap

Grade distribution of 248 stocks in Pharma & Biotech

S1A52B66C51D61F15